Knowing the consequences of psychedelics on human brain networks is essential to unlocking their therapeutic mechanisms. In humans, in the around six?hour length of action, psilocybin increases glutamate signalling and glucose metabolism19,twenty,21, broadly decreases the strength of electrophysiological signals22, minimizes hemodynamic fluctuation